UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000053350
Receipt number R000060580
Scientific Title A preterm infant life-saving package including a simple and affordable incubator and a portable flow generator mask-CPAP in resource-limited settings. SAVE Preterm trial, Saving preterm infants by Adopting Vital Equipment.
Date of disclosure of the study information 2024/01/16
Last modified on 2024/02/19 14:12:24

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A preterm infant life-saving package including a simple and affordable incubator and a portable flow generator mask-CPAP in resource-limited settings.
SAVE Preterm trial, Saving preterm infants by Adopting Vital Equipment.

Acronym

SAVE Preterm trial

Scientific Title

A preterm infant life-saving package including a simple and affordable incubator and a portable flow generator mask-CPAP in resource-limited settings.
SAVE Preterm trial, Saving preterm infants by Adopting Vital Equipment.

Scientific Title:Acronym

SAVE Preterm trial

Region

Asia(except Japan) Africa


Condition

Condition

Preterm birth complications

Classification by specialty

Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

The case fatality rate in preterm infants varies by their birth weight. We hypothesize that the package with an incubator and respiratory device would most effectively improve the mortality and morbidity of preterm infants. The incubator can safely provide a neutral environment, in which these newborn babies minimize their energy consumption, and the portable flow generator mask-CPAP can continuously provide the necessary breathing support. It can treat the complications of preterm infants, such as hypothermia and breathing problems. These devices are designed to be used in resource-limited settings and have the potential to save a large number of newborns in developing countries.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

The primary outcome is survival to hospital discharge. In the research area, patients may be discharged to home care if high mortality is anticipated. Such discharges are also included in the category of survival discharge.

Key secondary outcomes

The secondary outcome is in-hospital mortality within 28 days of birth including death confirmed through telephone follow-up post-discharge.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Body temperature management with a simple and affordable incubator and respiratory support with a portable flow generator mask-CPAP.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

2 days-old >

Gender

Male and Female

Key inclusion criteria

Preterm infants who birth weight are from 1,200 to 1,799g with respiratory failure.

Key exclusion criteria

Neonates with congenital malformations.

Target sample size

350


Research contact person

Name of lead principal investigator

1st name Eiji
Middle name
Last name Hirakawa

Organization

Kagoshima City Hospital

Division name

Department of Neonatology

Zip code

890-8760

Address

37-1 Ue-Arata, Kagoshima, Kagoshima, JAPAN

TEL

099-230-7000

Email

hirakawaeiji@gmail.com


Public contact

Name of contact person

1st name Eiji
Middle name
Last name Hirakawa

Organization

Kagoshima City Hospital

Division name

Department of Neonatology

Zip code

890-8760

Address

37-1 Ue-Arata, Kagoshima, Kagoshima, JAPAN

TEL

0990-230-7000

Homepage URL


Email

hirakawaeiji@gmail.com


Sponsor or person

Institute

Kagoshima City Hospital

Institute

Department

Personal name



Funding Source

Organization

Japan Agency for Medical Research and Development

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nagasaki University School of tropical medicine and global health

Address

1-12-4 Sakamoto, Nagasaki, Nagasaki, JAPAN

Tel

+81-95-819-7008

Email

tmgh_irb@ml.nagasaki-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

Savannakhet Provincial Hospital, Lao PDR.
Champasak Provincial Hospital, Lao PDR.
Khammouan Provincial Hospital, Lao PDR.
Saravan Provincial Hospital, Lao PDR.
Bo government Hospital, Republic of Sierra Leone.


Other administrative information

Date of disclosure of the study information

2024 Year 01 Month 16 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Preinitiation

Date of protocol fixation

2022 Year 12 Month 22 Day

Date of IRB

2022 Year 12 Month 22 Day

Anticipated trial start date

2024 Year 02 Month 01 Day

Last follow-up date

2025 Year 03 Month 01 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2024 Year 01 Month 15 Day

Last modified on

2024 Year 02 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000060580